Paper40778304
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.
Zhang K and 6 others. Front Aging Neurosci, 2025. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies. Papers, record 40778304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40778304
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References196
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11953750 | Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. | Nat Neurosci | 2002 | https://conductscience.org/library/papers/11953750 | PubMed |
| 2 | 16806844 | The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/16806844 | PubMed |
| 3 | 23593992 | Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? | CNS Neurosci Ther | 2013 | https://conductscience.org/library/papers/23593992 | PubMed |
| 4 | 39450669 | Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39450669 | PubMed |
| 5 | 23431156 | Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23431156 | PubMed |
| 6 | 16376149 | Glutamate-based therapeutic approaches: NR2B receptor antagonists. | Curr Opin Pharmacol | 2006 | https://conductscience.org/library/papers/16376149 | PubMed |
| 7 | 36116464 | Amyotrophic lateral sclerosis. | Lancet | 2022 | https://conductscience.org/library/papers/36116464 | PubMed |
| 8 | 20842175 | Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. | Nat Rev Neurosci | 2010 | https://conductscience.org/library/papers/20842175 | PubMed |
| 9 | 21792905 | Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. | J Cell Physiol | 2011 | https://conductscience.org/library/papers/21792905 | PubMed |
| 10 | 27662322 | Role of Glutamate and NMDA Receptors in Alzheimer's Disease. | J Alzheimers Dis | 2017 | https://conductscience.org/library/papers/27662322 | PubMed |
| 11 | 27447806 | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/27447806 | PubMed |
| 12 | 21172610 | Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. | Neuron | 2010 | https://conductscience.org/library/papers/21172610 | PubMed |
| 13 | 30890425 | Parkinson's Disease and Parkinsonism. | Am J Med | 2019 | https://conductscience.org/library/papers/30890425 | PubMed |
| 14 | 15722115 | Nitric oxide and neurological disorders. | Mol Aspects Med | 2005 | https://conductscience.org/library/papers/15722115 | PubMed |
| 15 | 32603820 | The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease. | Life Sci | 2020 | https://conductscience.org/library/papers/32603820 | PubMed |
| 16 | 34445070 | New Avenues for the Treatment of Huntington's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445070 | PubMed |
| 17 | 30293574 | N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/30293574 | PubMed |
| 18 | 16719816 | Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. | Curr Top Med Chem | 2006 | https://conductscience.org/library/papers/16719816 | PubMed |
| 19 | 37212097 | Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37212097 | PubMed |
| 20 | 17046312 | A pilot study of the clinical efficacy and safety of memantine for Huntington's disease. | Parkinsonism Relat Disord | 2007 | https://conductscience.org/library/papers/17046312 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940077 | Synaptic Function and Modulation in Health and Disease. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940077 | PubMed |
| 42936110 | Neuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation. | IBRO Neurosci Rep | 2026 | https://conductscience.org/library/papers/42936110 | PubMed |
| 42903380 | Hippocampal GluN2A knockdown differentially alters spatial exploration and behavioral performance in male and female rats. | Front Behav Neurosci | 2026 | https://conductscience.org/library/papers/42903380 | PubMed |
| 42889214 | Network-level restoration of impaired memory function in early Alzheimer's disease via GluN2B modulation: insights from a hippocampal CA1-CA3 model. | Front Comput Neurosci | 2026 | https://conductscience.org/library/papers/42889214 | PubMed |
| 42809650 | Motor dysfunction phenotypes in a drosophila model validate DAO as an ALS gene. | Hum Mol Genet | 2026 | https://conductscience.org/library/papers/42809650 | PubMed |
| 42576087 | The Amino Acid-Neurodegeneration Axis: Excitotoxicity and Oxidative Stress as Context-Dependent Amplifiers of Metabolic Dysfunction. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42576087 | PubMed |
| 42496921 | Phytochemicals with potential NMDAR-inhibitory activities: a review of neuroprotective mechanisms against excitotoxicity. | Saudi Pharm J | 2026 | https://conductscience.org/library/papers/42496921 | PubMed |
| 42444751 | Heterogeneous responses to memantine in Alzheimer's disease: A precision medicine approach using iPSC models. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42444751 | PubMed |
| 42436974 | A journey through the molecular networks of endomyocardial biopsies to explore ATTR and ALλ cardiac amyloidosis. | iScience | 2026 | https://conductscience.org/library/papers/42436974 | PubMed |
| 42402487 | Reduced expression of N-methyl-D-aspartate receptor and calcium signaling genes in gray matter is associated with cancer-related cognitive impairment. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42402487 | PubMed |
| 42319691 | A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42319691 | PubMed |
| 42268521 | Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson's and Huntington's Disease: Molecular Insights and Emerging Interventions. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42268521 | PubMed |
| 42198698 | From Envelope to Encephalopathy: How HIV-1 gp120 Drives Neurocognitive Decline. | Viruses | 2026 | https://conductscience.org/library/papers/42198698 | PubMed |
| 42111071 | Comparative characteristics of homocysteine and uric acid in patients with Parkinson's disease-related cognitive impairment and post-stroke cognitive impairment. | Front Neurol | 2026 | https://conductscience.org/library/papers/42111071 | PubMed |
| 41931177 | Chronic Co-administration of Methylphenidate and Fluoxetine Reduces Striatal NMDA Receptor Binding in Adolescent Rats. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41931177 | PubMed |
| 41899485 | Neurotransmitter Systems in Alzheimer's Disease. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899485 | PubMed |
| 41809078 | Polarity-determined triple partition of dual binding pockets unlocks mechanistic insights and a novel antagonist design of NMDA receptors: a combined MD/DFT study. | RSC Adv | 2026 | https://conductscience.org/library/papers/41809078 | PubMed |
| 41479443 | Osteoporosis-mediated exacerbation of the amyloid-β pathology: Involvement of serum calcium. | J Alzheimers Dis Rep | 2025 | https://conductscience.org/library/papers/41479443 | PubMed |
| 41133638 | NMDA Receptor: An Old but Refreshed Target for Neurodegeneration. | NeuroSci | 2025 | https://conductscience.org/library/papers/41133638 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| HTT | 3064 | PubTator's text mining | https://conductscience.org/library/genes/3064 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40778304
GET https://conductscience.org/api/papers/v1/40778304/references?page=2